Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Microneedling helps increase the absorption of a melanin product into hair follicles, which may improve laser hair removal effectiveness.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Microneedle patches with different pore sizes can effectively deliver drugs and trigger strong immune responses.

miR-21 helps improve ovarian function recovery in treated mice.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Many patients on methotrexate experience significant side effects but still continue the medication.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alefacept does not effectively treat severe alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.